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Cutaneous squamous cell carcinoma (SCC) is a common cancer. Although most patients with
primary cutaneous SCC have an excellent prognosis, for those with metastatic disease, the
long-term prognosis is poor. The most common sites of metastasis are regional lymph nodes,
lung, liver, brain, skin, and bone. However, metastatic soft tissue SCC from cutaneous lesions
is extremely rare, with only two reported cases. We report a case in which the patient had
a primary SCC lesion on his left palm in 1986. A second primary SCC on his left forearm
was confirmed in 2001, with subsequent metastasis to the proximal muscles and bone invasion
in spite of the initial wide excision.
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Cutaneous squamous cell carcinoma (SCC) is not an
uncommon skin lesion, especially in Caucasians. The
5-year rate of metastasis from primary cutaneous
lesions is 5% [1]. The incidence of metastasis increases
when the lesions are > 2 cm in width or 4 mm in depth,
are locally recurrent tumors, have poor histologic
differentiation, are found on the ears or lips, or occur
within scars or on non-sun-exposed skin, or when
there is histologic evidence of perineural involvement
or SCC occurs in immunosuppressed patients [2,3].
The most common site of metastasis is a regional
lymph node, while intramuscular metastasis is quite
rare. Bramhall and Varma reported a case of
intramuscular metastasis to the forearm from SCC on
the dorsal hand after wide excision and skin grafting
[4]. The lesion presented as cellulitis and a positive
axillary lymph node. Radiotherapy was the preferred
treatment. Kim et al reported a patient with a history
of scalp SCC and two kidney transplantations requiring
long-term immunosuppression who developed
intramuscular metastasis to the left proximal arm [5].
This patient underwent shoulder disarticulation and
axillary node dissection without radiotherapy or
chemotherapy. He remained disease-free at 8 months.
Due to the rarity of intramuscular metastasis from
cutaneous SCC, we present this case for discussion.
CASE PRESENTATION
A 64-year-old man presented with a 3-month history
of a soft tissue mass on his left forearm. He visited our
department in July 2001 because of recent rapid growth
and tenderness. An unhealing ulcer on his left palm
had first brought him to our department in 1986. Wide
excision with a reverse forearm flap closure was
performed for pathologically proven SCC (Figure 1).
Multiple erythematous papulae had been noted over
his trunk and extremities in recent years, but pathology
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proved them to be pre-malignant lesions only. A new
erythematous ulcerative lesion (3.5 x 3.5 cm) was noted
on his left forearm 2 years before this presentation and
biopsy later revealed SCC. Wide excision with a 2 cm
margin and a split-thickness skin graft were performed
in April 2001. The skin graft healed uneventfully, but
a left forearm soft tissue mass with tenderness was
noted by the patient 3 months after the operation
(Figure 2). Physical examination revealed a 6 x 5 cm
fixed, hard mass on the left forearm near the elbow,
with no broken skin or lesions over the skin graft or the
skin above the soft tissue mass. No palpable lymph
node over the axilla was found. Magnetic resonance
imaging (MRI) of the forearm showed that the tumor
was surrounded by the radius and ulna (Figure 3). The
tumor was some distance from the previous skin graft
and there were no structural abnormalities between
the skin graft and the tumor mass. Angiography
showed a hypervascular soft tissue tumor involving
the flexor and extensor muscle group of the forearm.
Wide excision was proposed, but failed due to inva-
sion of the bone. Frozen section showed intramuscular
SCC. Upper arm amputation was ultimately preferred.
The pathologist noted no cancer cells between the area
of the skin graft and the intramuscular lesion. Direct
invasion was excluded. Pathology demonstrated that
the intramuscular tumor was composed of squamoid
cancer cells with keratinization and formation of kera-
tin pearls focally, intense necrosis, and bone invasion
(Figures 4 and 5). After the operation, the patient was
transferred to an oncologist for systemic chemotherapy.
The patient remained disease-free at 22 months.
DISCUSSION
Mohs’ surgery affords a 96.9% 5-year rate of local
control in patients with primary cutaneous SCC at any
site except the lips or ears. In contrast, the 5-year rate
of local control with other forms of treatment is 92.1%
[1,2]. However, the 5-year survival rate of metastatic
Figure 1. Volar side of the left hand shows a reverse forearm flap
reconstruction of palm squamous cell carcinoma.
Figure 2. Dorsal side of the left forearm shows a healed skin graft
and a soft tissue mass with no skin lesion above the mass and an
intact skin graft. Markings show the planned wide excision that
failed due to bone invasion.
Figure 3. Sagittal, enhanced T1-weighted magnetic resonance
image shows a 6 x 5 cm enhanced tumor (arrow) attached to the
radial shaft. Normal tissue intervenes between the previous skin
graft (arrowhead) and the intramuscular mass. The artifact is due
to a surgical clip over the skin graft.
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SCC is only 43.6% [1]. This is quite different from the
excellent prognosis for primary cutaneous SCC.
We were concerned about the route of metastasis.
The modes of spread mentioned by Mohs include
expansion and infiltration, shelving or skating, conduit
spread, and metastasis [6,7]. In our case, there was no
tumor cell infiltration of subcutaneous fat, no evidence
of a muscle plane or periosteum plane for shelving,
and no tumor cells over the perineural or perivascular
space on histology. Metastasis may have occurred by
hematogenous or lymphatic spread since it occurred
at a distance from the previous lesion and soft tissue
mass.
The reasons for the rarity of intramuscular
metastasis from cutaneous SCC are unclear. It has
been reported that the milieu of skeletal muscle tissue
may not be optimal for tumor cell viability because of
the difficulty of expression of cellular adhesion
molecules, variable turbulent blood flow, and the
higher level of lactic acidosis within highly mobile
skeletal muscle tissue [8,9]. From the molecular
perspective, the process of metastasis involves an
intricate interplay between cell adhesion, proteolysis,
migration, and angiogenesis [10]. In angiogenesis, the
interaction of cancer cells with endothelial cells through
adhesion molecules is critical for the generation of
functional vascular networks that will nourish cancer
cell nests and promote in vivo tumor growth [11].
High levels of adhesion molecules are demonstrated
in patients with metastatic cancer [12]. In conclusion,
the expression of adhesion molecules is important in
angiogenesis, but it is difficult in the microenvironment
of skeletal muscle due to high mobility. This may be
the reason why metastatic deposits rarely develop to a
microscopic size in skeletal muscle.
Intramuscular metastasis developed after tumor
excision with skin graft in a previous case [4] and our
case. In neither case did the skin graft break down, nor
was there local recurrence. The immobility of the skin
graft may make tumor cell nest angiogenesis possible
in the highly mobile muscle. The initial relatively
ischemic skin graft wound has even less possibility of
spreading, although the mechanism is unclear.
Diagnosis of intramuscular metastatic SCC is
difficult. Kransdorf et al suggested that MRI is a pre-
ferred modality for the evaluation of soft tissue masses
[13]. There is, however, no defined differential of in-
tramuscular metastatic SCC and soft tissue sarcoma
by such imaging. Ultimately, biopsy remains the only
method of diagnosing a highly suspicious lesion. A
thorough history of cutaneous SCC may be the key to
suspecting a metastatic lesion.
Due to the rarity of intramuscular metastasis from
cutaneous SCC, there is still much to be learned about
its treatment. In our patient’s case, axillary lymph
node dissection was not performed due to lack of
clinical evidence of lymph node metastasis. However,
the oncologist suggested chemotherapy because of the
possibility of distal metastasis.
In summary, for cases with large or deeply invasive
cutaneous SCC, complete resection of the tumor mass
is recommended. Physical examination should then be
performed regularly to assess the possibility of local or
regional recurrence, including lymphadenopathy. If a
soft tissue mass develops in a patient with a history of
cutaneous SCC, metastasis should be assumed, unless
Figure 5. Keratin pearl formation. (Hematoxylin and eosin,
original magnification x 40.)
Figure 4. Intramuscular squamous cell carcinoma. Cancer cells
are inside the skeletal spindle cells. The skin and subcutaneous fat
are intact. (Hematoxylin and eosin, original magnification x 2.)
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biopsy proves otherwise. Glass and Hoover reported
that 12% of their patients with cutaneous SCC had new
SCC, 43% had new basal cell carcinoma, and 2% had
melanoma [14]. In a population-based study in Sweden,
Wassberg et al found that patients with SCC, com-
pared with the general population, have an increased
risk of developing new primary cancer [15]. Long-
term follow-up is necessary for early detection of new
lesions. However, because of the rarity of intramuscu-
lar metastasis, what constitutes optimal management
is still not known, and multimodal treatment, includ-
ing chemotherapy and radiation, must be considered.
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